English
Español
Français
Português
Русский
简体中文
English
Español
Français
Português
Русский
简体中文
12:00
Epidemiological analysis of the number of deaths by skin cancer, between 2016 and 2020 in Brazil
12:00
Clinical accuracy of non-melanoma skin cancer lesions in a dermatology referral hospital
12:00
Epidemiological analysis of non-melanoma skin cancer in a dermatology referral hospital
12:00
Body localization of non-melanoma skin cancer in a dermatology referral hospital
12:00
Effects of cross-linked HA fillers on metabolism, function and gene expression in human adipose tissue explants: ex vivo study (unrestricted educational grant from Fillmed Laboratoires)
12:00
Subject-relevant outcomes of on-label 50U AbobotulinumtoxinA treatment for moderate-to-severe glabellar lines across three individual studies (unrestricted educational grant from Galderma)
12:00
Subject satisfaction with AbobotulinumtoxinA for moderate-to-severe glabellar lines: a randomized, dose-escalating, double-blind study (unrestricted educational grant from Galderma)
12:00
A randomized, placebo-controlled study of AbobotulinumtoxinA for treatment of glabellar lines using a new dilution and injection volume (unrestricted educational grant from Galderma)
12:00
AbobotulinumtoxinA for the treatment of moderate-to-severe glabellar lines: a randomized, dose-escalating, double-blind study (unrestricted educational grant from Galderma)
12:00
A study of combined microfocused ultrasound and hyaluronic acid dermal filler in the treatment of enlarged facial pores in Asians
12:00
High-risk actinic cheilitis treated with fractionated ablative carbon dioxide laser in combination with TCA 30% peel and topical tretinoin 0.05% cream
12:00
Millennial subject satisfaction with two treatments of AbobotulinumtoxinA a year (unrestricted educational grant from Galderma)
12:00
Subject satisfaction with two treatments a year (every six months) of AbobotulinumtoxinA is high among both previously treated and toxin-naive cohorts (unrestricted educational grant from Galderma)
12:00
Intermittent microalveolar stromal stimulation therapy: lower legs functional and cosmetic reshaping by lympho-venous network activation (unrestricted educational grant from icoone/I-Tech Industries Srl)
